tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mike Matson, 798 are a BUY (82.95%), 160 are a HOLD (16.63%), 4 are a SELL (0.42%).
Analyst Mike Matson, currently employed at NEEDHAM, carries an average stock price target met ratio of 65.1% that have a potential upside of 26.94% achieved within 332 days.
Mike Matson’s has documented 1,755 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Technology, Financial Services, Industrials, Utilities sectors.
Most recent stock forecast was given on MMSI, Merit Medical Systems at 29-Sep-2026.
Analyst best performing recommendations are on PSNL (PERSONALIS).
The best stock recommendation documented was for PSNL (PERSONALIS) at 8/8/2024. The price target of $5.5 was fulfilled within 8 days with a profit of $2.07 (60.35%) receiving and performance score of 75.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Aug-2016
$64
$8.86 (16.07%)
$45
1 months 4 days ago
(02-Sep-2026)
38/46 (82.61%)
$11.41 (21.70%)
463
Buy Since 11-Oct-2018
$60
$4.86 (8.81%)
$50
1 months 9 days ago
(27-Aug-2026)
25/26 (96.15%)
$10.73 (21.78%)
179
Buy Since 19-Feb-2020
$55
$-0.14 (-0.25%)
$54
1 months 12 days ago
(24-Aug-2026)
9/13 (69.23%)
$5.72 (11.61%)
225
Buy Since 24-Feb-2021
$53
$22.82 (75.61%)
$64
7 months 18 days ago
(18-Feb-2026)
2/19 (10.53%)
$20.74 (64.29%)
36
Buy Since 23-Oct-2023
$52
$21.82 (72.30%)
$60
7 months 18 days ago
(18-Feb-2026)
0/5 (0%)
$19.74 (61.19%)
Which stock is Mike Matson most bullish on?
Which stock is Mike Matson most reserved on?
What Year was the first public recommendation made by Mike Matson?
